GlassScriptAtriclip Laa Exclusion System
Payments companies reported to CMS as associated with Atriclip Laa Exclusion System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Atriclip Laa Exclusion System, per program year, as reported to CMS.
Who makes it
- Atricure, INC. $1.9M associated with Atriclip Laa Exclusion System (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Atriclip Laa Exclusion System
These are the largest totals companies reported as associated with Atriclip Laa Exclusion System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kevin Makati | Lutz, FL | Cardiovascular Disease | $34,928.17 |
| Eric Okum | Columbus, OH | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $24,875.33 |
| Armin Kiankhooy | Saint Helena, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $23,869.60 |
| Nitesh Sood | Fall River, MA | Clinical Cardiac Electrophysiology | $22,840.95 |
| Zayd Eldadah | Washington, DC | Clinical Cardiac Electrophysiology | $18,000.46 |
| Andrew Sherman | Tampa, FL | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $17,698.70 |
| Mario Gasparri | Milwaukee, WI | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $17,210.92 |
| Israel Jacobowitz | Brooklyn, NY | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $16,335.06 |
| Steven Peterson | Louisville, KY | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $16,222.17 |
| Helenmari Merritt | Omaha, NE | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $14,176.89 |
Prescribed Atriclip Laa Exclusion System?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.